Program on Science, Technology and Society at Harvard

Harvard Kennedy School of Government | Harvard University

Editorial Aspirations Speakers

Speakers

 

K. Anthony Appiah

Professor K. Anthony Appiah was educated at Clare College, Cambridge University, in England, where he took both B.A. and Ph.D. degrees in the philosophy department. Since Cambridge, he has taught at Yale, Cornell, Duke, and Harvard universities and lectured at many other institutions in the United States, Germany, Ghana and South Africa, as well as at the École des Hautes Études en Sciences Sociales in Paris; and from 2002 to 2013 he was a member of the Princeton University faculty, where he had appointments in the Philosophy Department and the University Center for Human Values, as well as being associated with the Center for African American Studies, the Programs in African Studies and Translation Studies, and the Departments of Comparative Literature and Politics. In January 2014 he took up an appointment as Professor of Philosophy and Law at New York University, where he teaches both in New York and in Abu Dhabi and at other NYU global centers. Among his books are Cosmopolitanism: Ethics in a World of Strangers and The Ethics of Identity; and he writes the weekly Ethicist column for the New York Times.

Elizabeth Bartholet

Elizabeth Bartholet is the Morris Wasserstein Public Interest Professor of Law at Harvard Law School, and Faculty Director of the Child Advocacy Program (CAP) which she founded in the fall of 2004. She teaches civil rights and family law, specializing in child welfare, adoption and reproductive technology. Before joining the Harvard Faculty, she was engaged in civil rights and public interest work, first with the NAACP Legal Defense Fund, and later as founder and director of the Legal Action Center, a non-profit organization in New York City focused on criminal justice and substance abuse issues. Bartholet graduated from Radcliffe College in 1962, and from Harvard Law School in 1965.

 

 

Francoise Baylis

Françoise Baylis, Professor and Canada Research Chair in Bioethics and Philosophy at Dalhousie University, has particular interest and expertise in the ethics of heritable genetic modification. She was an external reviewer for the Institute of Medicine 2016 report “Mitochondrial Replacement Techniques”. She was also a member of the 12-person Organizing Committee for the December 2015 International Summit on Human Gene Editing. Baylis’ research aims to move the limits of mainstream bioethics. She is currently working on developing effective strategies to tackle public policy challenges in Canada and abroad. She believes bioethicists need to take on greater advocacy roles and use their talents and expertise in pursuit of social justice. They need to create welcoming spaces for meaningful deliberation and discussion that engages people whose interests and voices have traditionally been marginalized. As well, they need to find creative ways to make the powerful care. Baylis is an elected fellow of both the Royal Society of Canada and the Canadian Academy of Health Sciences. Her many recent honours include appointments in 2016 to both the Order of Canada and the Order of Nova Scotia.

Gaymon Bennett

Gaymon Bennett is assistant professor of Religion, Science, and Technology at Arizona State University. His work explores the cultural significance of biotechnology, with particular focus on how the making of new technologies functions as an experiment with old questions: what life means, where it’s going, and who gets to decide. He was a founding member of the human practices initiative at the Synthetic Biology Engineering Research Center at UC Berkeley, and co-organizer of the Center for Biological Futures at Fred Hutchinson in Seattle. He is author of Technicians of Human Dignity: Bodies, Souls, and the Making of Intrinsic Worth, and co-author of Designing Human Practices: An Experiment with Synthetic Biology, and Sacred Cells?: Why Christians Should Support Stem Cells Research. He holds PhDs in Cultural Anthropology (UC Berkeley) and Philosophical Theology (Graduate Theological Union, Berkeley).

 

 

George Church

George Church is Professor at Harvard & MIT, co-author of 450 papers, 95 patent publications & the book Regenesis. He developed methods used for the first genome sequence (1994) & genome recoding & million-fold cost reductions since.  He co-initiated the BRAIN Initiative (2011) & Genome Projects (1984, 2005) to provide & interpret world’s only open-access personal precision medicine data.

Photo credit: Wyss Institute at Harvard University

 

 

 

I. Glenn Cohen

A member of the inaugural cohort of Petrie-Flom Academic Fellows, Glenn was appointed to the Harvard Law School faculty in 2008 and is currently Faculty Director of the Petrie-Flom Center. Glenn is one of the world’s leading experts on the intersection of bioethics (sometimes also called “medical ethics”) and the law, as well as health law. He also teaches civil procedure. From Seoul to Krakow to Vancouver, Glenn has spoken at legal, medical, and industry conferences around the world and his work has appeared in or been covered on PBS, NPR, ABC, CNN, MSNBC, Mother Jones, the New York Times, the New Republic, the Boston Globe, and several other media venues.

 

 

George Q. Daley

George Q. Daley, MD, PhD is the Dean of Harvard Medical School. He is also the Caroline Shields Warren Professor of Medicine and Professor of Biological Chemistry and Molecular Pharmacology. Daley’s research pertains to stem cells, cancer and blood disorders. He received his bachelor’s degree, magna cum laude, from Harvard (1982), a doctorate in biology from MIT (1989), and his medical degree from Harvard Medical School (1991). He served as president of the International Society for Stem Cell Research from 2007 to 2008 and as its clerk from 2012 to 2015. He anchored the special task forces that produced the society’s guidelines for stem cell research (2006), clinical translation (2008) and their subsequent revisions and updates (2016).

 

 

Kevin Esvelt

Kevin Esvelt is director of the Sculpting Evolution group at the MIT Media Lab, which invents new ways to study and influence the evolution of ecosystems. By carefully developing and testing these methods with openness and humility, the group seeks to address difficult ecological problems for the benefit of humanity and the natural world. Prior to joining the MIT Media Lab, Esvelt wove many different areas of science into novel approaches to ecological engineering. He invented phage-assisted continuous evolution (PACE), a synthetic microbial ecosystem for rapidly evolving biomolecules, in the laboratory of David R. Liu at Harvard University. At the Wyss Institute, he worked with George Church to develop the CRISPR system for genome engineering and regulation, and he began exploring the use of bacteriophages and conjugation to engineer microbial ecosystems. Esvelt is credited as the first to describe how CRISPR gene drives could be used to alter the traits of wild populations in an evolutionarily stable manner. And recently, he and his Sculpting Evolution group devised a new form of technology, called ‘daisy drives’, which would let communities aiming to prevent disease alter wild organisms in local ecosystems.

Kevin Finneran

Kevin Finneran is editor-in-chief of Issues in Science and Technology, a quarterly policy magazine published by the National Academies of Sciences, Engineering, and Medicine; the University of Texas at Dallas; and Arizona State University. He is also the former director of the National Academies’ Committee on Science, Engineering, Medicine, and Public Policy. He was one of the organizers of the December 2015 Summit on Human Genome Engineering, which was sponsored by the US National Academies of Sciences and Medicine, the UK Royal Society, and the Chinese Academy of Sciences.

 


J. Bryan Hehir

J. Bryan Hehir is the Parker Gilbert Montgomery Professor of the Practice of Religion and Public Life. He is also the Secretary for Health Care and Social Services in the Archdiocese of Boston. His research and writing focus on ethics and foreign policy and the role of religion in world politics and in American society. He served on the faculty of Georgetown University (1984 to 1992) and the Harvard Divinity School (1993 to 2001). His writings include: “The Moral Measurement of War: A Tradition of Continuity and Change; Military Intervention and National Sovereignty; Catholicism and Democracy;” and “Social Values and Public Policy: A Contribution from a Religious Tradition.”

 

Stephen Hilgartner

Stephen Hilgartner is Professor of Science & Technology Studies at Cornell University. His research examines the social dimensions and politics of contemporary and emerging science and technology, especially in the biosciences. He is particularly interested in social studies of genomics, synthetic biology, and emerging technologies. His most recent book, Reordering Life: Knowledge and Control in the Genomics Revolution, will be published by MIT Press in May 2017. Recent publications include the co-edited volume Science & Democracy: Making Knowledge and Making Power in the Biosciences and Beyond (2015), and papers in BioSocieties, British Journal for History of Science, GigaScience, and the Sociology of the Sciences Yearbook. His book Science on Stage: Expert Advice as Public Drama, which examines how scientific advisory bodies work to produce credible recommendations, won the Carson Prize from the Society for Social Studies of Science.

J. Benjamin Hurlbut

J. Benjamin Hurlbut, PhD is Assistant Professor of Biology and Society in the School of Life Sciences at Arizona State University. He is trained in science and technology studies with a focus on the history of the modern biomedical and life sciences.  His research lies at the intersection of STS, bioethics and political theory.  Hurlbut studies the changing relationships between science, politics and law in the governance of biomedical research and innovation in the 20th and 21st centuries, examining the interplay of science and technology with shifting notions of democracy, of religious and moral pluralism, and of public reason. He is the author of Experiments in Democracy: Human Embryo Research and the Politics of Bioethics (Columbia University Press, 2017). He holds an A.B. from Stanford University, and a Ph.D. in the History of Science from Harvard University. He was a postdoctoral fellow in the Program on Science, Technology and Society at the John F. Kennedy School of Government at Harvard.

William B. Hurlbut

William B. Hurlbut is a physician and Adjunct Professor in the Department of Neurobiology at Stanford University Medical Center. His primary areas of interest involve the ethical issues associated with advancing biomedical technology, the biological basis of moral awareness, and studies in the integration of theology and philosophy of biology. In addition to teaching at Stanford, he has worked with NASA on projects in astrobiology and as a member of the Chemical and Biological Warfare working group at Stanford’s Center for International Security and Cooperation. He has organized and co-chaired three multi-year interdisciplinary faculty projects at Stanford University, “Becoming Human: The Evolutionary Origins of Spiritual, Religious and Moral Awareness,” “Brain Mind and Emergence,” and the ongoing “The Boundaries of Humanity: Human, Animals, and Machines in the Age of Biotechnology.” In addition, he is Co-leader, together with U.C. Berkeley professor Jennifer Doudna of a new initiative entitled “The challenge and opportunity of gene editing: a project for reflection, deliberation and education. ”From 2002-2009 Dr. Hurlbut served on the President’s Council on Bioethics.

Rudolf Jaenisch

Rudolf Jaenisch is a Founding Member of the Whitehead Institute for Biomedical Research and a Professor of Biology at the Massachusetts Institute of Technology. He is a pioneer in making transgenic mice, some of which have produced important advances in understanding cancer, neurological and connective tissue diseases, and developmental abnormalities and has explored basic questions such as the role of DNA modification, genomic imprinting and X chromosome inactivation.  The laboratory is renowned for its expertise in cloning mice and in studying the myriad factors that contribute to the success and failure cellular reprogramming.  More recently the lab has focused on using the iPS cell system to study diseases such as Alzheimer’s, Parkinson’s and Autism.

Dr. Jaenisch is a Member of the National Academy of Sciences and the International Society for Stem Cell Research.  In 1996 he was honored with the Boehringer Mannheim Molecular Bioanalytics Prize, in 2001 was the recipient of the first ever Peter Gruber Foundation Award in Genetics, in 2002 won the Robert Koch Prize for Excellence in Scientific Achievement, the March of Dimes Prize in 2015 and in 2011 was a recipient of the United States National Medal of Science. In 2014 he was president of the ISSCR.

Sheila Jasanoff

Sheila Jasanoff is Pforzheimer Professor of Science and Technology Studies at the Harvard Kennedy School. A pioneer in her field, she has authored more than 120 articles and chapters and is author or editor of more than 15 books, including The Fifth Branch, Science at the Bar, Designs on Nature, and The Ethics of Invention. Her work explores the role of science and technology in the law, politics, and policy of modern democracies, with particular attention to the nature of public reason. She was founding chair of the STS Department at Cornell University and has held numerous distinguished visiting appointments. Jasanoff served on the Board of Directors of the American Association for the Advancement of Science and as President of the Society for Social Studies of Science. She has received a Guggenheim Fellowship, the Sarton Chair of the University of Ghent, and an Ehrenkreuz from the Government of Austria. She holds AB, JD, and PhD degrees from Harvard, and an honorary doctorate from the University of Twente.

Rev. John Paul Kimes

Rev. John Paul Kimes is the Raymond of Peñafort Fellow in Canon Law at the Center for Ethics and Culture. He was ordained a priest in the eparchy of Our Lady of Lebanon of Los Angeles in 2000 and currently serves at the Congregation for the Doctrine of the Faith in the Vatican. He received his B.A. from the University of Notre Dame, an S.T.B. in theology from the Pontifical Gregorian University in Rome, and a Ph.D. in canon law from the Pontifical Oriental Institute in Rome. His recent publications include articles on the canonical situation of Eastern Catholics in the multi-Church context of the United States, implications of the norms of Anglicanorum Coetibus on the Eastern Catholic Churches, and various aspects of the work of the Congregation for the Doctrine of the Faith, particularly on the application of the norms of Sacramentorum Sanctitatis Tutela.

Laurence Lwoff

Mrs Laurence LWOFF is currently the Head of Bioethics Unit (DGI – Human Rights Directorate) and Secretary of the Committee on Bioethics (DH-BIO), intergovernmental committee in charge of the activities on the protection of human rights in the biomedical field, at the Council of Europe. She joined the Council of Europe in 1991, where she was entrusted with the responsibilities of the Secretariat of the Conventions concerning the use of animals in agriculture and science, in the Directorate of Legal Affairs. In 1999, her responsibilities were extended to biotechnology. She was the Secretary of the International Conference of the Council of Europe on Ethical Issues Arising from the Applications of Biotechnology (Oviedo, Spain, May 1999). In 2002, she joined the Bioethics Department where she has been responsible in particular for the activities on human genetics and on the protection of the human embryo and the foetus. She was the Secretary of the Group in charge of the elaboration of the Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Genetic Testing for Health Purposes.

 

Gerald L. Neuman 


Gerald L. Neuman is the J. Sinclair Armstrong Professor of International, Foreign, and Comparative Law, and the Co-Director of the Human Rights Program at HLS. He teaches human rights, constitutional law, and immigration and nationality law. His current research focuses on international human rights bodies, transnational dimensions of constitutionalism, and rights of foreign nationals. He is the author of Strangers to the Constitution: Immigrants, Borders and Fundamental Law (Princeton 1996), and co-author of the casebook Human Rights (with Louis Henkin et al., Foundation Press). Prior to joining HLS in 2006, he served on the faculties of the University of Pennsylvania Law School (1984-1992) and Columbia Law School (1992-2006). From 2011 to 2014, he was a member of the Human Rights Committee, the treaty body that monitors compliance with the International Covenant on Civil and Political Rights.

 

Peter Mills

Peter Mills is Assistant Director at the Nuffield Council on Bioethics, an independent body that examines and reports on ethical issues in biology and medicine. His work relates to a wide range of issues at the intersection of science, ethics and public policy, and has included major reports on emerging biotechnologies (2012), the linking and re-use of data in biomedical research and health care (2015) and genome editing (2016). Previously, Peter has held posts at the UK’s Human Fertilisation and Embryology Authority (HFEA) and Department of Health, where he was Head of Human Genetics and Bioethics. As well as overseeing a number of national policy reviews he has led the secretariat for the UK’s Human Genetics Commission (a cross-departmental strategic advisory body) and represented the UK Government on international bioethics bodies, including the Council of Europe Bioethics Committee.

 

 

Buhm Soon Park

Buhm Soon Park is Professor of History of Science and Policy at Korea Advanced Institute of Science and Technology, and a Senior Visiting Research Fellow in the Harvard Kennedy School’s STS Program. His research explores policy issues at the intersection between science, law, and governance from historical and comparative perspective. He currently works on the imaginaries of biomedicine in the U.S., focusing on the history of the NIH, and examines the debates over new and emerging technologies like synthetic biology and genome editing in East Asia. He received his Ph.D. in history of science from the Johns Hopkins University, and spent several years at the NIH as a postdoctoral fellow. He has publications in wide-ranging topics, such as the history of quantum chemistry, NIH intramural programs, and science policy in East Asia.

 

 

Duanqing Pei

Duanqing Pei is Professor of stem cell biology and also serves as the Director General (President) at the Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences, in Guangzhou, China. He obtained his PhD from the University of Pennsylvania in 1991 and trained as a postdoctoral fellow at the University of Michigan before becoming a faculty member at the University of Minnesota School of Medicine in 1996. He joined the Medical Faculty at Tsinghua University in Beijing China in 2002 and moved to the newly formed GIBH in 2004. After studying the transcription regulation of hepatitis B virus (HBV) for his Ph.D. thesis by identifying C/EBP as a repressor for HBV transcription and dissecting the transactivation domains in C/EBP, he shifted t into the field of extracellular matrix remodeling by studying the structure and function of matrix metalloproteinases (MMPs). He cloned several novel members of the MMP family, uncovered the unique intracellular activation mechanism of MMPs with the proprotein convertase system, and the intracellular trafficking of membrane-bound MMPs. Upon returning to China, he ostarted working on pluripotency first and then reprogramming. The Pei lab in Tsinghua began to publish in the stem cell field on the structure and function of Oct4, Sox2, FoxD3, Essrb, and Nanog, and their interdependent relationship towards pluripotency. Based the understanding of these factors, the Pei lab was the first in China to create mouse iPSCs using a non-selective system, and then improved the iPS process systematically. Now, his lab continues to explore new ways to improve iPS technology, dissect the reprogramming mechanisms driven by Oct4/Sox2/Klf4 or fewer factors, and employ iPSCs to model human diseases in vitro.

 

Tobias Rees

Tobias Rees hold the William Dawson Chair in the Faculty of Medicine at McGill University and is both a Fellow of the Canadian Institute of Advanced Research (CIFAR) and of the Nicolas Berggruen Institute (Los Angeles). His expertise lies at the intersection of anthropology, art history, the history of science, and the philosophy of modernity and concerns the study of knowledge/thought. More specifically, he is interested in how categories that order knowledge mutate over time –– because of humans, microbes, snails, the weather, AI or other events –– and in what effects these mutations have on conceptions of the human/the real. The main areas of Professor Rees’ research have been the brain sciences  global health, microbiology, and AI (big data based machine learning).

 

 

Krishanu Saha 

Krishanu Saha is an Assistant Professor of Biomedical Engineering and Medical History & Bioethics at the University of Wisconsin. His research interests are in gene-editing human stem cells for regenerative medicine. He leads a lab at the UW-Madison that is uniquely engaged with ethical and social implications of frontier biotechnologies. His lab is now funded by the NIH, NSF and EPA to perform high-impact research on pluripotent stem cells, regenerative medicine, disease modeling and synthetic biology. He is a member of the National Academies’ Forum on Regenerative Medicine. In addition to being a scientific leader in the stem cell engineering field, he is deeply engaged with the ethical and social implications of gene-editing, for example by co-authoring a recent piece in Issues in Science and Technology and participating in the 2015 International Summit on Human Gene Editing and 2016/17 OECD BNCT Workshops on Gene Editing. He is on the Executive Committees of the Stem Cell and Regenerative Medicine Center and the Robert F. and Jean E. Holtz Center for Science & Technology Studies at the UW-Madison.

Rachel Salzman

Dr. Rachel Salzman serves as Chief Scientific Officer of The Stop ALD Foundation (SALD), and has held this position since 2001. SALD is a non-profit Medical Research Organization dedicated to employing entrepreneurial approaches and innovative methodology to advance effective therapies, cures, and prevention of x-linked adrenoleukodystrophy (ALD), an often fatal neurodegenerative disease. The biomedical interests of the Foundation include gene therapy, hematopoietic stem cells and other adult stem cells, genomics, and small molecules. In this context SALD made critical contributions to the groundbreaking ex vivo lenti trial conducted in pediatric patients in France, which is now a pivotal clinical study sponsored by a publicly owned US-based biotech. Dr. Salzman also advises large pharma and biotech in the field of drug development, including preclinical and clinical analysis in oncology, CNS disorders, and orphan indications. Prior to these roles, Rachel worked in clinical veterinary practice. She has a D.V.M. from Oklahoma State University and a B.S. from Rutgers University.

 

Abha Saxena

Dr. Abha Saxena leads the work of the Global Health Ethics Unit at the World Health Organization – the world’s premier health institution that directs and coordinates global health through the United Nations system.  She has responsibility for coordinating WHO’s work on bioethics, and public health and research ethics.  Internally, she heads Secretariats of the Research Ethics Review Committee (ERC), the Public Health Ethics Consultative Group, and the Global Summit of National Bioethics Advisory Bodies (NEC) as well as the Ethics Resource Centre.  Externally, she ensures that effective global and intergovernmental action for health is based on ethical principles.  Her team is the focal point for the examination of ethical issues raised by current agendas and activities throughout the WHO, including responding to regional and country offices, and Member States, and supports the implementation of ethical considerations in the elaboration and implementation of health policies and research activities at a global level, build global consensus on ethics topics and harmonize ethical standards. Under her leadership several normative and standard setting documents, as well as training tools have been published, both in the area of research and public health.

 

Tania Simoncelli

Tania Simoncelli is Executive Director of the Count Me In initiative and Senior Advisor to the Director at the Broad Institute of MIT and Harvard. Previously, Simoncelli served for two years as Assistant Director for Forensic Science and Biomedical Innovation within the White House Office of Science and Technology Policy, and for three years as Special Assistant to FDA Commissioner Margaret Hamburg.  From 2003-2010, Simoncelli served as Science Advisor to the American Civil Liberties Union, where she spearheaded the ACLU’s successful efforts to invalidate patents on the BRCA genes and end the practice of gene patenting in the United States.  In 2013, Simoncelli was named by the journal Nature as one of “ten people who mattered this year” for her work in overturning gene patents.  Simoncelli received a B.A. in Biology and Society from Cornell University and an M.S. in Energy and Resources from UC Berkeley.

 

Carter Snead

Professor Carter Snead is internationally recognized as a leading expert in public bioethics – the governance of science, medicine, and biotechnology in the name of ethical goods. He has authored more than 40 journal articles, book chapters, and essays in such publications as the New York University Law Review, the Harvard Law Review Forum, the Vanderbilt Law Review, and Political Science Quarterly. He is also the editor of two book series for the University of Notre Dame Press. Snead served as General Counsel to The President’s Council on Bioethics; led the U.S. government delegation to UNESCO and served as its chief negotiator for the Universal Declaration on Bioethics and Human Rights; served as the U.S. government’s Permanent Observer to the Council of Europe’s Steering Committee on Bioethics; served on UNESCO’s International Bioethics Committee; and was appointed to the Holy See’s Pontifical Academy for Life.

Kaushik Sunder Rajan 

Kaushik Sunder Rajan is Associate Professor of Anthropology at the University of Chicago. Originally trained as a biochemist, Sunder Rajan received his PhD in the History and Social Studies of Science and Technology at the Massachusetts Institute of Technology in 2002. He works on the global political economy of the life sciences and biomedicine, with a primary empirical focus on the United States and India. His recent book Pharmocracy: Value, Politics and Knowledge in Global Biomedicine (Duke, 2017), explains the structure and operation of the hegemony of the global pharmaceutical industry through case studies from contemporary India. He is also the author of Biocapital: The Constitution of Post-Genomic Life (Duke, 2006) and editor of Lively Capital: Biotechnologies, Ethics and Governance in Global Markets. Sunder Rajan is currently co-Director of the Chicago Center for Contemporary Theory (3ct).

Robert D. Truog

Robert D. Truog, MD, is the Frances Glessner Lee Professor of Medical Ethics, Anaesthesia and Pediatrics at Harvard Medical School, where he serves as Director of the Center for Bioethics, leading educational and academic initiatives across the medical school, including an undergraduate curriculum, a Master’s degree and a Fellowship program. He has also served as Chair of the Harvard Embryonic Stem Cell Research Oversight Committee since 2005. He has practiced pediatric intensive care medicine at Boston Children’s Hospital for more than 30 years, including serving as Chief of the Division for more than a decade. He has published more than 250 articles and books in bioethics and related disciplines, including “Talking with patients and families about medical error” (2010, Hopkins) and Death, dying, and organ transplantation (2012, Oxford). In 2013 he was honored with the Spinoza Chair at the University of Amsterdam.

 

Daniel Wikler

Daniel Wikler is Mary B. Saltonstall Professor of Ethics and Population Health at the Harvard Chan School of Public Health. He served as the first Staff Ethicist for World Health Organization, and is co-author of the WHO’s Casebook in Ethical Issues in International Health Research. With Dr. Richard Cash, he taught the research ethics course focusing on international health research at Harvard School of Public Health for over a decade, as well as an intensive course on this subject taught annually at Harvard and also in over 25 developing countries. He has been a member of IRBs at Harvard and at WHO for over 30 years. His most recent publication in research ethics is “Must Research Benefit Human Subjects If It Is To Be Permissible?”, Journal of Medical Ethics, 2016.

 

Patricia Williams

Patricia Williams is the James L. Dohr Professor of Law at Columbia Law School. She has served on the faculties of the University of Wisconsin School of Law, City University of New York Law School, and Golden Gate University School of Law. Williams was a fellow at the School of Criticism and Theory, Dartmouth College, as well as at the Center for Advanced Study in the Behavioral Sciences. Williams practiced as deputy city attorney for the Office of the Los Angeles City Attorney and as staff lawyer for the Western Center on Law and Poverty. She is published widely in the areas of race, gender, and law, and on other issues of legal theory and legal writing. Her books include The Alchemy of Race and Rights; The Rooster’s Egg; and Seeing a ColorBlind Future: The Paradox of Race. Williams has also been a columnist for The Nation. Williams was a MacArthur fellow, and served on the board of trustees at Wellesley College. She earned her J.D. from Harvard Law School in 1975 and her B.A. from Wellesley College in 1972.

Christiane Woopen

Christiane Woopen is Professor for Ethics and Theory of Medicine at the University of Cologne. There she is Executive Director of the Cologne Center for Ethics, Rights, Economics, and Social Sciences of Health (ceres). She is as well Head of Research Unit Ethics and vice dean for academic development and gender at the University Hospital Cologne. She is coordinator and leader of several international and national research projects concerning ethical aspects of reproductive medicine, neuroethics, quality of life, aging, digital autonomy and genome editing. She is former chair of the German Ethics Council, President of the 11th Global Summit of National Ethics/Bioethics Committees 2016 and amongst others member of the International Bioethics Committee of UNESCO as well as of the European Group on Ethics of Science and New Technologies. Prof. Woopen received her medical degree from the University of Bonn and worked in gynecology and obstetrics before focusing on bioethics.

 

Feng Zhang

Feng Zhang is a McGovern Investigator and an Associate Professor in the Departments of Brain and Cognitive Sciences and of Biological Engineering. He is also a core member of the Broad Institute of MIT and Harvard. He joined MIT and the Broad Institute in 2011 and was awarded tenure in 2016. Feng Zhang grew up in Iowa after moving there with his parents from China at age 11. He received his A.B. in chemistry and physics from Harvard College and his PhD in chemistry from Stanford University. Zhang has received many awards for his work in genome editing and optogenetics, including the Perl/UNC Prize in Neuroscience (2012, shared with Karl Deisseroth and Ed Boyden), the NIH Director’s Pioneer Award (2012), the National Science Foundation’s Alan T. Waterman Award (2014), the Jacob Heskel Gabbay Award in Biotechnology and Medicine (2014, shared with Jennifer Doudna and Emmanuelle Charpentier), the Society for Neuroscience Young Investigator Award (2014), the Okazaki award, the Canada Gairdner International Award (shared with Doudna and Charpentier along with Philippe Horvath and Rodolphe Barrangou) and the 2016 Tang Prize (shared with Doudna and Charpentier). Zhang is a founder of Editas Medicine, a genome editing company founded by world leaders in the fields of genome editing, protein engineering, and molecular and structural biology.